ibandronic acid liconsa 150 mg õhukese polümeerikattega tablett
laboratorios liconsa s.a. - ibandroonhape - õhukese polümeerikattega tablett - 150mg 3tk; 150mg 1tk
ossica õhukese polümeerikattega tablett
gedeon richter plc. - ibandroonhape - õhukese polümeerikattega tablett - 50mg 28tk; 50mg 84tk
licobondrat 150 mg õhukese polümeerikattega tablett
laboratorios liconsa s.a. - ibandroonhape - õhukese polümeerikattega tablett - 150mg 1tk; 150mg 3tk
abiraterone zentiva õhukese polümeerikattega tablett
zentiva k.s. - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk
abiraterone viasana õhukese polümeerikattega tablett
viasana uab - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk
onureg
bristol-myers squibb pharma eeig - asatsitidiin - leukeemia, müeloidne, äge - antineoplastilised ained - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
diabufor xr toimeainet prolongeeritult vabastav tablett
farmak international sp. z o.o. - metformiin - toimeainet prolongeeritult vabastav tablett - 750mg 90tk; 750mg 60tk; 750mg 30tk
diabufor xr toimeainet prolongeeritult vabastav tablett
farmak international sp. z o.o. - metformiin - toimeainet prolongeeritult vabastav tablett - 500mg 90tk
diabufor xr toimeainet prolongeeritult vabastav tablett
farmak international sp. z o.o. - metformiin - toimeainet prolongeeritult vabastav tablett - 1000mg 90tk; 1000mg 30tk; 1000mg 60tk